Compare Stocks

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASL Argentum Silver	C$0.04 -11.1%	C$0.03	C$0.03 ▼ C$0.07	C$2.06M	1.71	11,262 shs	20,000 shs
ASND Ascendis Pharma A/S	$143.18 -1.1%	$149.15	$66.03 ▼ $161.00	$8.34B	0.5	368,340 shs	244,223 shs
DAU Desert Gold Ventures	C$0.06 -7.7%	C$0.07	C$0.03 ▼ C$0.10	C$11.73M	1.7	172,828 shs	310,000 shs
ECC Eagle Point Credit	$10.03 +0.1%	$10.06	$8.60 ▼ $11.79	$771.42M	0.77	691,672 shs	377,497 shs
XAG Xtierra	C$0.03 -28.6%	C$0.02	C$0.02 ▼ C$0.07	C$4.89M	0.88	36,989 shs	7,000 shs

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASL Argentum Silver	0.00%	-11.11%	+33.33%	+60.00%	-42.86%
ASND Ascendis Pharma A/S	+1.92%	+2.35%	-0.13%	+7.99%	+81.56%
DAU Desert Gold Ventures	0.00%	-18.75%	-7.14%	+85.71%	+44.44%
ECC Eagle Point Credit	+0.45%	+1.11%	+0.25%	-1.04%	-11.83%
XAG Xtierra	0.00%	0.00%	0.00%	0.00%	0.00%

Exposed: 10 CENT Crypto to Explode April 20th? (Ad)

Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin

Click For My #1 FREE Crypto for 2024

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ASL Argentum Silver	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	1.359 of 5 stars	3.4	1.0	0.0	0.0	1.8	1.7	0.6
DAU Desert Gold Ventures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ECC Eagle Point Credit	2.0809 of 5 stars	1.3	5.0	1.7	0.0	3.9	0.0	1.9
XAG Xtierra	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ASL Argentum Silver	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	2.88	Moderate Buy	$173.25	21.00% Upside
DAU Desert Gold Ventures	N/A	N/A	N/A	N/A
ECC Eagle Point Credit	2.50	Moderate Buy	$11.00	9.73% Upside
XAG Xtierra	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest DAU, ASND, XAG, ECC, and ASL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/22/2024	ASND Ascendis Pharma A/S	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$116.00 ➝ $116.00
4/18/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$173.00
4/2/2024	ASND Ascendis Pharma A/S	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$165.00 ➝ $167.00
4/1/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$173.00
3/15/2024	ASND Ascendis Pharma A/S	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$196.00 ➝ $260.00
2/8/2024	ASND Ascendis Pharma A/S	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$146.00 ➝ $182.00
2/8/2024	ASND Ascendis Pharma A/S	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$207.00 ➝ $225.00
2/6/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$152.00 ➝ $173.00

(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ASL Argentum Silver	N/A	N/A	C$0.01 per share	3.16	N/A	N/A
ASND Ascendis Pharma A/S	$266.72M	31.26	N/A	N/A	($2.73) per share	-52.45
DAU Desert Gold Ventures	N/A	N/A	C$0.00 per share	60.00	N/A	N/A
ECC Eagle Point Credit	$139.07M	5.55	$1.15 per share	8.71	$9.21 per share	1.09
XAG Xtierra	N/A	N/A	C$0.00 per share	50.00	C($0.01) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ASL Argentum Silver	N/A	-C$0.01	N/A	∞	N/A	N/A	-88.18%	-37.68%	5/24/2024 (Estimated)
ASND Ascendis Pharma A/S	-$521.07M	-$9.25	N/A	N/A	N/A	-180.61%	-16,574.15%	-55.10%	4/25/2024 (Estimated)
DAU Desert Gold Ventures	-C$1.27M	-C$0.01	N/A	∞	N/A	N/A	-3,951.95%	-180.42%	6/4/2024 (Estimated)
ECC Eagle Point Credit	$118.75M	$1.78	5.63	7.11	N/A	84.05%	14.27%	10.23%	5/21/2024 (Estimated)
XAG Xtierra	N/A	N/A	N/A	∞	N/A	N/A	N/A	-3.18%	N/A

Latest DAU, ASND, XAG, ECC, and ASL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/25/2024	N/A	ASND Ascendis Pharma A/S	N/A	-$1.60	-$1.60	N/A	N/A	N/A
2/22/2024	Q4 2023	ECC Eagle Point Credit	$0.38	$0.33	-$0.05	$0.29	$39.10 million	$39.39 million
2/7/2024	Q4 2023	ASND Ascendis Pharma A/S	-$2.15	-$1.66	+$0.49	-$1.66	$97.02 million	$148.62 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ASL Argentum Silver	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	N/A	N/A	N/A	N/A	N/A
DAU Desert Gold Ventures	N/A	N/A	N/A	N/A	N/A
ECC Eagle Point Credit	$1.68	16.76%	+8.37%	94.38%	N/A
XAG Xtierra	N/A	N/A	N/A	N/A	N/A

Latest DAU, ASND, XAG, ECC, and ASL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/20/2024	ECC Eagle Point Credit	monthly	$0.14	16.9%	6/10/2024	6/10/2024	6/28/2024
2/13/2024	ECC Eagle Point Credit	monthly	$0.14	16.9%	5/10/2024	5/13/2024	5/31/2024
2/13/2024	ECC Eagle Point Credit	monthly	$0.14	16.9%	4/9/2024	4/10/2024	4/30/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ASL Argentum Silver	N/A	5.83	14.02
ASND Ascendis Pharma A/S	N/A	3.56	2.50
DAU Desert Gold Ventures	124.81	2.39	0.54
ECC Eagle Point Credit	0.22	6.60	6.60
XAG Xtierra	N/A	N/A	0.00

Ownership

Institutional Ownership

Company	Institutional Ownership
ASL Argentum Silver	N/A
ASND Ascendis Pharma A/S	N/A
DAU Desert Gold Ventures	7.85%
ECC Eagle Point Credit	19.50%
XAG Xtierra	N/A

Insider Ownership

Company	Insider Ownership
ASL Argentum Silver	62.18%
ASND Ascendis Pharma A/S	40.00%
DAU Desert Gold Ventures	4.85%
ECC Eagle Point Credit	0.24%
XAG Xtierra	38.93%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ASL Argentum Silver	N/A	51.60 million	N/A	Not Optionable
ASND Ascendis Pharma A/S	879	58.22 million	34.93 million	Optionable
DAU Desert Gold Ventures	N/A	195.47 million	N/A	Not Optionable
ECC Eagle Point Credit	N/A	76.95 million	76.76 million	Not Optionable
XAG Xtierra	N/A	195.69 million	N/A	Not Optionable

DAU, ASND, XAG, ECC, and ASL Headlines

Source	Headline
	XAG/SAR - Silver Spot Saudi Riyal investing.com - April 20 at 12:31 PM
	US Dollar Index News: Fed’s Cautious Tone Bolsters DXY’s Short-Term Prospects fxempire.com - April 19 at 9:23 PM
	Silver Prices Forecast: Traders Eyeing Psychological Target at $30 fxempire.com - April 11 at 3:29 PM
	XAG/PKR - Silver Spot Pakistani Rupee investing.com - April 10 at 6:35 PM
	XPD/XAG - Palladium Spot Silver Spot investing.com - April 5 at 10:55 PM
	XAG/ILS - Silver Spot Israeli Shekel investing.com - April 1 at 9:44 PM
	Daily Silver Price in Europe • Silver Price in Euro • XAG in EUR prokerala.com - March 31 at 2:04 PM
	Daily Silver Price in Kuwait • Silver Price in Kuwaiti Dinar • XAG in KWD prokerala.com - March 27 at 10:09 AM
	Silver Prices Forecast: How Will Fed’s Rate Decision Impact XAG/USD Momentum? fxempire.com - March 27 at 10:09 AM
	Silver Prices Forecast: Fed Policy, Global Central Banks Set to Propel XAG/USD fxempire.com - March 22 at 6:25 AM
	XAG/QAR - Silver Spot Qatari Riyal investing.com - March 16 at 7:19 PM
	Silver Prices Forecast: XAG/USD Grapples with Dollar Might and Rate Uncertainties fxempire.com - March 15 at 1:16 AM
	Daily Silver Price in Bahrain • Silver Price in Bahraini Dinar • XAG in BHD prokerala.com - February 27 at 3:02 PM
	Silver Price Analysis: XAG/USD rallies amid risk-on mood, low US yields fxstreet.com - February 26 at 12:36 AM
	XPT/XAG - Platinum Spot Silver Spot investing.com - January 24 at 2:22 AM
	Convert New Zealand Dollar To Silver Ounce forbes.com - January 3 at 9:47 AM
	Silver lurches higher as markets wrap up 2023, XAG/USD rebounds from $24.00 fxstreet.com - December 29 at 10:34 PM
	Convert Silver Ounce To Iraqi Dinar forbes.com - December 1 at 1:45 PM
	XAG/USD: Technical Analysis investing.com - November 30 at 4:17 PM
	XAG/RUB Technical Analysis investing.com - November 10 at 6:51 PM
	Convert Hungarian Forint To Silver Ounce forbes.com - November 2 at 8:54 AM
	Convert Swedish Krona To Silver Ounce forbes.com - October 30 at 9:53 PM
	Silver Spot Multi-Contributor reuters.com - October 8 at 1:45 PM
	Convert Swiss Franc To Silver Ounce forbes.com - September 25 at 9:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Argentum Silver

CVE:ASL

Argentum Silver Corp., a junior mineral exploration company, engages in the acquisition, exploration, evaluation, and development of mineral properties in Canada and Peru. It holds 100% interest in the Cochavara silver-lead-zinc project comprising six concessions covering an area of approximately 3,479 hectares located in La Libertad, northern Peru. The company was formerly known as Silex Ventures Ltd. and changed its name to Argentum Silver Corp. in February 2011. Argentum Silver Corp. was incorporated in 2007 and is headquartered in Toronto, Canada. Argentum Silver Corp. operates as a subsidiary of Sprott Mining Inc.

Ascendis Pharma A/S

NASDAQ:ASND

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Desert Gold Ventures

CVE:DAU

Desert Gold Ventures Inc., an exploration stage company, engages in the acquisition, exploration, and development of mineral resource properties in Mali. The company primarily explores for gold ores. Its flagship project is the Senegal Mali Shear Zone project located in Western Mali. Desert Gold Ventures Inc. was incorporated in 2003 and is headquartered in Surrey, Canada.

Eagle Point Credit

NYSE:ECC

Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.

Xtierra

CVE:XAG

Xtierra Inc., a natural resource company, engages in the exploration and development of precious and base metal deposits in Mexico. It primarily explores for zinc, silver, lead, copper, gold, and mercury deposits. The company holds 100% interest in the Bilbao project located to the northwest of Mexico City in the southeastern part of the State of Zacatecas; and the Laguna silver-gold-mercury project. Xtierra Inc. is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial